Skip to content

Drug interactions

Cobimetinib + Zileuton

Severity: Moderate

Cobimetinib and Zileuton: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Zileuton is a weak CYP3A4 inhibitor and may modestly increase cobimetinib exposure. Higher cobimetinib levels could worsen toxicities such as rash, diarrhea, hemorrhage, liver injury and retinal disorders.

What this interaction means in plain words

Cobimetinib and Zileuton can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Cobimetinib belongs to Oncology; Zileuton belongs to Respiratory.

Evidence level: Low

Why it happens

Inhibition of CYP3A4 metabolism of cobimetinib by zileuton.

What to do

No fixed dose change is generally needed for a weak inhibitor, but monitor for cobimetinib adverse effects and liver enzymes. Reduce the dose or interrupt therapy if toxicity develops.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Cobimetinib and Zileuton, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Cobimetinib with Zileuton?

MediHelp rates the interaction as moderate. Cobimetinib and Zileuton can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Zileuton is a weak CYP3A4 inhibitor and may modestly increase cobimetinib exposure. Higher cobimetinib levels could worsen toxicities such as rash, diarrhea, hemorrhage, liver injury and retinal disorders.

How serious is the interaction between Cobimetinib and Zileuton?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: No fixed dose change is generally needed for a weak inhibitor, but monitor for cobimetinib adverse effects and liver enzymes. Reduce the dose or interrupt therapy if toxicity develops.

What other medicines interact with Zileuton?

MediHelp also lists interactions of Zileuton with, for example, Fezolinetant, Pimozide, Alosetron. The full list is on the Zileuton page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in